City State Bank Viatris Inc Transaction History

City State Bank

$272 Million
Q3 2024

A detailed history of City State Bank transactions in Viatris Inc stock. As of the latest transaction made, City State Bank holds 10,142 shares of VTRS stock, worth $131,846. This represents 0.04% of its overall portfolio holdings.

Number of Shares

10,142

Previous 10,242 0.98%

Holding current value

$131,846

Previous $108,000 8.33%

% of portfolio

0.04%

Previous 0.04%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$10.32 - $12.13 $1,032 - $1,213	-100 Reduced 0.98%	10,142 $117,000
Q2 2024 Jul 08, 2024	SELL	$10.05 - $12.02 $6,030 - $7,212	-600 Reduced 5.53%	10,242 $109,000
Q4 2023 Jan 10, 2024	SELL	$8.77 - $10.85 $7,059 - $8,734	-805 Reduced 6.91%	10,842 $117,000
Q3 2023 Oct 16, 2023	SELL	$9.59 - $11.35 $9,705 - $11,486	-1,012 Reduced 7.99%	11,647 $115,000
Q2 2023 Jul 10, 2023	SELL	$9.02 - $10.29 $4,510 - $5,145	-500 Reduced 3.8%	12,659 $126,000
Q1 2023 Apr 10, 2023	SELL	$9.2 - $12.26 $11,886 - $15,839	-1,292 Reduced 8.94%	13,159 $127,000
Q4 2022 Jan 11, 2023	SELL	$8.72 - $11.56 $8,981 - $11,906	-1,030 Reduced 6.65%	14,451 $161,000
Q3 2022 Oct 24, 2022	SELL	$8.48 - $11.13 $2,221 - $2,916	-262 Reduced 1.66%	15,481 $132,000
Q2 2022 Aug 22, 2022	BUY	$9.95 - $12.27 $13,790 - $17,006	1,386 Added 9.65%	15,743 $165,000
Q1 2022 Jun 01, 2022	SELL	$9.81 - $15.4 $2,305 - $3,619	-235 Reduced 1.61%	14,357 $156,000
Q4 2021 Mar 23, 2022	BUY	$12.09 - $14.68 $2,768 - $3,361	229 Added 1.59%	14,592 $197,000
Q4 2021 Mar 11, 2022	BUY	$12.09 - $14.68 $173,648 - $210,848	14,363 New	14,363 $147,000

Others Institutions Holding VTRS

# of Institutions

1,102

Shares Held

934M

Call Options Held

2.71M

Put Options Held

2.4M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of City State Bank, based on Form 13F filings with the SEC.

News

Stay updated on City State Bank with notifications on news.

Account